NFSG
RNTX

Newbridge Financial Services Group’s Rein Therapeutics RNTX Stock Holding History

Newbridge Financial Services Group’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$126 Buy
+97
New +$120 ﹤0.01% 1146
2025
Q2 		– Sell
-11,194
Closed -$19.8K – 1376
2025
Q1 		$19.8K Buy
+11,194
New +$23.5K ﹤0.01% 546
2024
Q4 		– Sell
-25,000
Closed -$88.5K – 1195
2024
Q3 		$88.5K Buy
+25,000
New +$66.8K 0.03% 205

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Newbridge Financial Services Group's RNTX Position: Q1 2026 in Review

Newbridge Financial Services Group opened a new position in Rein Therapeutics (RNTX) in Q1 2026: 97 shares worth $126. The stake represents ﹤0.01% of the portfolio and ranks #1146 among its holdings. This is a return to the name: Newbridge Financial Services Group previously reported a position in RNTX as recently as Q1 2025.

Newbridge Financial Services Group first reported a position in RNTX in Q3 2024 and has held it in 3 quarters since. The position peaked at $88.5K in Q3 2024. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • Newbridge Financial Services Group held 97 shares of Rein Therapeutics worth $126 as of Q1 2026.
  • Rein Therapeutics was a new Newbridge Financial Services Group position in Q1 2026.
  • Rein Therapeutics made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #1146 holding.
  • Newbridge Financial Services Group first reported a position in Rein Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Newbridge Financial Services Group's Rein Therapeutics position peaked at $88.5K in Q3 2024.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.